Purchase Order HHSN269201700511P

<p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>

The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $15,090 on July 28, 2017, with ultimate completion by August 27, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The purchase covers molecular diagnostics products and consumables, consistent with Qiagen's core offerings in DNA/RNA extraction kits, reagents, and related laboratory supplies supporting the Clinical Center's biomedical research and diagnostic...

<p>The NIH Clinical Center issued a purchase order to Qiagen, LLC on June 12, 2018 for $7,808.68 with firm fixed-price pricing and an ultimate completion date of June 20, 2018. Performance is at Bethesda, Maryland. The source does not specify what is being purchased.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $17,680.81 on June 15, 2018, with an ultimate completion date of June 29, 2018. The order is firm fixed price with no set-aside designation. Place of performance is Bethesda, Maryland. The source does not disclose the specific items or services procured under this purchase order.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,064 purchase order to Qiagen, LLC. Under this firm fixed price contract, Qiagen will provide products or services to the NIH Clinical Center in Germantown, Maryland between September 2023 and September 2024. As a division of Qiagen N.V., Qiagen, LLC will leverage its parent company's expertise in sample and assay technologies to support the NIH Clinical Center's biomedical research and...

Qiagen, LLC received a $29,166.25 firm fixed-price purchase order from the NIH Clinical Center, awarded on January 1, 2026, with a completion date of December 31, 2026. This contract carries no set-aside designation, allowing Qiagen to compete in the open federal marketplace. The award is for delivery to Germantown, Maryland, where Qiagen maintains its headquarters operations. As a foreign-owned manufacturer specializing in molecular diagnostics, scientific equipment, and bioinformatics...

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC for $15,058.45 on September 19, 2012, with ultimate completion on September 13, 2013. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside category. Specific procurement details are not described in the source.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $7,735.00 on August 28, 2017, with final completion on September 28, 2017. The order is firm fixed price with no set-aside designation. Place of performance is Bethesda, Maryland.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $15,500.00 with an award date of March 13, 2020 and ultimate completion date of March 12, 2021. Performance occurs in Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. The specific commodities or services procured are not detailed in the source.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $8,165.40 on November 22, 2017, with a completion date of December 1, 2017. Performance will occur in Bethesda, Maryland. The order is firm fixed price and carries no set-aside designation. The specific products or services procured are not detailed in the source material.</p>